Filing Details
Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 29, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:INDV
Indivior Pharmaceuticals, Inc. (INDV) Files Quarterly Report for Q0
Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on October 29, 2026.
At publication ·
What changed
Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Indivior Pharmaceuticals filed its Q0 2026 quarterly report (Form 10-Q) on October 29, 2026 with the SEC.
- The company's stock trades at $35.25 with a market capitalization of $4.5 billion.
- The 10-Q filing contains unaudited financial statements and management commentary on business performance and emerging trends.
Market Context
Indivior Pharmaceuticals, Inc.'s stock currently trades at $35.25 with a market capitalization of $4.5B.
The 10-Q provides Indivior Pharmaceuticals, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Indivior Pharmaceuticals, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View INDV Stock Page
Frequently Asked Questions
Where can I read INDV's SEC filings?
Browse all filings on our INDV SEC filings page.
What types of SEC filings does Indivior Pharmaceuticals, Inc. file?
Public companies like Indivior Pharmaceuticals, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.